New therapy for kids with leukemia receives FDA approval

Yesterday, the FDA approved the first gene therapy available in the United States, CAR  T cell therapy, for kids with leukemia. Read the announcement here.
This new therapy was developed through years of research by the Pediatric Cancer Dream Team and Dr. Stephan Grupp of Children’s Hospital of Philadelphia, supported since 2013 jointly by the St. Baldrick’s Foundation and Stand Up to Cancer.
Compete for a Cause has been donating half of our annual proceeds for the last three years to the St. Baldrick’s Foundation supporting childhood cancer research.
This is a big win for childhood cancer and shows that together we can make a positive difference in the lives of children battling cancer.
We thank you.  Your support of Compete for a Cause and in turn our support of St. Baldrick’s helped make this encouraging step in our fight against childhood cancer possible.  The timing couldn’t be better as we get ready to kick off our 2017 Compete for a Cause events.   Be sure to spread the word, sign up for the 5k run/walk, order your t-shirt, and join us in filling the stands on Sept. 16 as we come together to fuel the steps to come!